By Jade Martinez-Pogue ( January 24, 2023, 6:57 PM EST) -- An Albireo Pharma investor on Tuesday sued the biotechnology company and its board of directors in federal court, accusing them of violating securities laws by filing an incomplete and misleading recommendation statement in connection with the planned sale of the business to a French pharmaceutical company....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.